Michael Terribile
Dermatology · Rock Hill, SCNPI 1720140643
Payments from drug & device makers
Across 541 payments — averaging $16.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Sanofi$944
- Lilly USA, LLC$879
- AbbVie$783
- Sun Pharmaceutical Industries Inc.$752
- LEO Pharma Inc.$632
- plus $4K from 24 others
What the payments were for
- Food & beverage$8,62595%
- Education$4975%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 42 | $1,105 |
| Sanofi | 51 | $944 |
| Lilly USA, LLC | 38 | $879 |
| AbbVie | 57 | $783 |
| Sun Pharmaceutical Industries Inc. | 38 | $752 |
| LEO Pharma Inc. | 38 | $632 |
| E.r. Squibb & Sons, L.L.C. | 37 | $594 |
| Dermavant Sciences, Inc. | 65 | $557 |
| Galderma Laboratories, L.p. | 39 | $436 |
| Novartis | 17 | $380 |
| Regeneron Healthcare Solutions, Inc. | 20 | $335 |
| Arcutis Biotherapeutics, Inc. | 23 | $286 |
| Amgen | 14 | $282 |
| Pfizer | 14 | $237 |
| Incyte Corporation | 7 | $156 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $142 |
| Organon | 10 | $97 |
| VYNE Pharmaceuticals Inc. | 4 | $83 |
| Journey Medical Corporation | 3 | $80 |
| Biofrontera Inc. | 5 | $75 |
| Almirall LLC | 2 | $44 |
| UCB, Inc. | 2 | $42 |
| Cipher Pharmaceuticals US LLC | 1 | $42 |
| Organogenesis Inc. | 1 | $32 |
| EPI Health, LLC | 2 | $30 |
| Janssen Scientific Affairs, LLC | 1 | $22 |
| Mayne Pharma Commercial LLC | 1 | $22 |
| LNHC, Inc | 1 | $20 |
| Botanix SB Inc | 1 | $19 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $13 |
How this compares
$9,121 in reported general payments places this provider in the 70th percentile of 203 dermatology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 15 | $56,308 |
| Clobetasol Propionate | 162 | $6,554 |
| Tacrolimus | 36 | $3,759 |
| Alclometasone Dipropionate | 69 | $3,521 |
| Ketoconazole | 114 | $2,427 |
| Triamcinolone Acetonide | 187 | $2,373 |
| Metronidazole | 64 | $2,173 |
| Doxycycline Hyclate | 106 | $1,845 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 16 | $1,550 |
| Clindamycin Phosphate | 36 | $1,137 |
| Desonide | 19 | $1,136 |
| Fluocinonide | 25 | $758 |
| Fluocinolone Acetonide | 18 | $743 |
| CiclopiroxCiclopirox Olamine | 12 | $552 |
| Hydroxyzine Hcl | 17 | $349 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Rock Hill
- Kylee SackstederRock Hill$13K
- Todd SchlesingerCharleston$6.4M
- Matthew MillerGreenville$2.8M
- Marshall ShulerGreenville$2.6M
- Rebecca SmithFort Mill$2.3M
- Amylynne FrankelSpartanburg$1.3M
- Theresa KnoeppAnderson$977K
- Jessica BurgyColumbia$519K
- Richard SturtzAnderson$369K
- John KormanGreer$210K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.